Asymchem Laboratories News

Gloria Ying (002821): Small molecule CDMO gross margin continues to increase, and emerging businesses are expected to resume growth

cscNov 5 07:47

Gloria Ying (002821): New orders continue to maintain a good trend and look forward to business resumption in Q4

sealand SecuritiesNov 2 00:00

Gloria Ying (002821): Gross margin improved month-on-month, peptides increased and overseas layout increased

gtjaNov 1 15:27

Gloria Ying (002821): Small molecules maintain growth trend and peptides are progressing steadily

china international capital corporationNov 1 00:00

Gloria Ying (002821): Small molecule businesses resume growth and absorb large orders, production capacity, and the bottom-up stage of emerging businesses

West SecuritiesOct 31 00:00

Gloria Ying (002821): New orders maintain a good trend, and the company's operations are expected to improve marginally

Guotou SecuritiesOct 30 13:26

Gloria Ying (002821): Small molecule business growth is gradually recovering, optimistic about future development

swhy ResearchOct 30 07:41

Gloria Ying (002821): Marginal improvement in the third quarter is optimistic about the company's bottom reversal

sinolinkOct 29 00:00

Gloria Ying (002821): Regular business revenue growth accelerated marginally in 3Q24

htscOct 29 00:00

Bocom Intl: rates the Mainland pharmaceutical industry as "leading", focusing on innovative and consumer-driven targets.

Zhitong FinanceOct 17 09:53

Gloria Ying (002821): The company's continued repurchases show confidence that growth is expected to gradually resume in the future

Swhy ResearchOct 10 07:36

Gloria Ying (002821): Strong new signings, M volume can be expected

Sep 11 07:16

Gloria Ying (002821) 2024H1 review: Excluding large orders affects the steady growth of the main business, and the gradual recovery of new orders

Sep 3 00:00

Gloria Ying (002821): Performance showed steady growth, and the order side showed marginal improvement

Aug 30 00:00

Gloria Ying (002821): Regular business growth, on-hand orders guarantee development

Aug 29 15:56

Gloria Ying (002821): Sufficient orders in hand to deepen overseas production capacity layout

Aug 29 15:46

Gloria Ying (002821): Large order base affects apparent performance, new order growth accelerates

Aug 29 15:16

Gloria Ying (002821): 1H24's regular business revenue continues to grow

Aug 29 00:00

Gloria Ying (002821) 2024 Semi-Annual Report Review: Strong growth in new orders accelerates the layout of overseas bases and peptide production capacity

Aug 29 00:00

Gloria Ying (002821): New orders are signed to gradually improve the steady development of various businesses

Aug 28 00:00